Advice from BAREC and College: Use of external platform for recruitment

This advice was prepared jointly by BAREC and the College Board and approved for publication on 03/08/2026. It outlines the conditions and recommendations for the use of external platforms in the recruitment of participants for clinical trials.

Interfederal Drug Strategy 2026-2029

INTERFEDERAL STRATEGY FOR A COMPREHENSIVE AND INTEGRATED DRUGS POLICY 2026-2029

Guidance on the compensation of clinical research participants

This document is a BAREC guidance document containing information concerning the compensation of participants in clinical research. This guidance has been endorsed by the College Board on 10/10/2025.

2025 figures for euthanasia in Belgium

In 2025, 4,486 euthanasia registration documents were received and reviewed by the Federal Commission for the Control and Evaluation of Euthanasia , marking a 12.4% increase compared with 2024. Euthanasia accounted for 4% of all deaths recorded in Belgium in 2025, , compared to 3.6% in 2024 (source...

Annual Report 2024 of the CT-College

This annual report provides an overview of the activities carried out by the College during the period from January to December 2024, relating to dossiers governed by the CTR/MDR/IVDR regulations implemented in Belgium through the laws of 2017, 2020, and 2022 respectively. You will find an overview...

Advice from BAREC for hospitals regarding the green light procedure (10/10/2025)

This advice was prepared by BAREC and approved by the College Board on 10/10/2025. The purpose of this advice is to raise awareness among study sites about the importance of ensuring that their internal procedures do not result in delaying the start of clinical studies.

Advice from BAREC regarding the retention periods for study documents in clinical research (10/10/2025)

This advice was prepared by BAREC and approved by the College Board on 10/10/2025. The advice provides an overview of the retention periods applicable to study documents within research projects, in accordance with current legal requirements. These retention periods may vary depending on the type of...

BAREC statement for the sponsors and ECs on the collection of ethnicity data in clinical trials (10/10/2025)

This statement was prepared by BAREC and approved by the College Board on 10/10/2025. The statement clarifies the collection of ethnic information from the target population of clinical studies.

Advice from BAREC for sponsors and EC's on the anonymization of samples and the lifting of traceability of human bodily material

This document addresses the anonymization of samples and the lifting of traceability of human bodily material. It was prepared by BAREC, revised by experts from the College Board, and approved on November 14, 2025. This recommendation explains how to inform participants about the anonymization of...

Advice from College and FAMHP to sponsors and sites of clinical studies on the need for an updated ICH-GCP certificate for new submissions after the implementation of ICH-GCP (R3) on 23/07/2025

Here you will find an advice from the College and the FAMHP to the sponsors and sites of clinical studies on the need for an updated ICH-GCP certificate for new submissions after the implementation of ICH-GCP (R3) on 23/07/2025.